Zap Energy

Phase A — Understand the business

Company Overview

Zap Energy is a Seattle-founded (2017) private fusion developer commercializing the sheared-flow-stabilized (SFS) Z-pinch — a fusion concept that confines and compresses plasma using only the plasma's own axial electric current and the magnetic field that current generates, with a sheared axial flow suppressing the instabilities that killed classical Z-pinches. The one-sentence business: build a fusion core with no superconducting magnets and no high-power lasers, so the machine is "garage-sized," cheap, and mass-manufacturable rather than a stadium-scale tokamak.

• Founded: 2017, Seattle WA; labs in Everett + Mukilteo WA.
• Headcount: ~150 (2025).
• Status: private; World Economic Forum "Technology Unicorn" (>$1B) June 2023; no S-1, no IPO filed.
• The April-2026 redefinition (the single most important fact in this dossier): Zap declared itself the first "fission-fusion" company, adding a near-term nuclear-fission product line alongside the long-horizon fusion program, and installed a fission/defense-native CEO to run deployment. It now sells two products on two timelines: fission for revenue this decade, fusion for the moonshot.

Products/assets (all pre-revenue R&D devices; the "products" are milestones, not SKUs):

• FuZE / FuZE-Q / FuZE-3 — the physics line, chasing scientific breakeven (Q>1).
• Century — the engineering line: an integrated power-plant test platform proving repetitive pulsed power, flowing liquid-metal walls, and electrode survival.
• Fission reactor — to be based on the Toshiba/CRIEPI 4S ("Super-Safe, Small & Simple") sodium-cooled fast micro-reactor design.

Customers today: effectively the U.S. government (DOE Milestone program; targeted DoD/DOE fission programs) and, prospectively, power-hungry AI/data-center buyers who would pre-reserve capacity. No commercial customers, no revenue disclosed. Contract structure to date is non-dilutive, milestone-gated federal cost-share (see Lens 9).

Supply Chain

Map (upstream inputs → Zap → end use), named where public:

• Physics IP origin: University of Washington (Uri Shumlak's group) + Lawrence Livermore National Laboratory (LLNL), which provided the independent 2021 neutron validation.
• Pulsed-power hardware: Zap vertically integrated a key input by acquiring the liquidated assets of pulsed-power manufacturer ICAR (June 2023) to build its own high-voltage capacitor/switch stacks in-house — a deliberate de-risking of the single most specialized supply input. This is the standout supply-chain move: pulsed-power components (capacitors, spark-gap/solid-state switches) are the scarce, long-lead item for any Z-pinch, and owning the line is a genuine chokepoint hedge.
• Electrodes / plasma-facing materials: graphite and liquid-metal-tipped cathodes — the erosion-limited consumable at the heart of the engineering risk (Lens 3/13). Liquid-metal wall + cathode systems are the mitigation Century exists to prove.
• Fuel: deuterium (D-D) today; deuterium-tritium (D-T) for a commercial plant → tritium supply + breeding is an industry-wide chokepoint Zap has not publicly solved.
• Fission leg: the 4S design is Toshiba + CRIEPI (Japan) IP — Zap does not own it outright; sodium-fast-reactor fuel + liquid-sodium systems are a separate, specialized supply chain with its own single-source Japanese heritage.

Chokepoints: (1) pulsed-power components — partially internalized via ICAR; (2) durable high-duty-cycle electrodes — unsolved, active R&D; (3) tritium — unsolved, sector-wide; (4) 4S licensing/fuel — externally owned, never US-deployed. Names present → lens satisfied; but the D-T fuel cycle and 4S fuel supply are the two thin spots.

Competitive Advantages (moats)

The Zap thesis is a cost/complexity moat, not a performance moat:

• No magnets, no lasers. Every dollar not spent on high-temperature-superconducting (HTS) magnets (Commonwealth Fusion) or a National-Ignition-Facility-class laser bay (Pacific Fusion, Xcimer, laser ICF names) is the entire pitch. Zap has reached >1 keV, gigapascal-class plasma "in systems that are a fraction of the size and cost of fusion devices of comparable performance" (VP Ben Levitt). The moat is capital efficiency per unit of scientific progress (see Lens 7 comps: ~$327M raised vs CFS's ~$3B ).
• Manufacturability / scalability. A small core is a mass-produced unit, not a megaproject — the Felix-Dennis-of-fusion argument that many cheap machines beat one heroic one.
• Foundational IP + institutional pedigree. Two-plus decades of SFS Z-pinch work at UW (ZaP → ZaP-HD → FuZE), LLNL collaboration, and peer-reviewed physics (APS DPP, Physics of Plasmas, Fusion Science & Technology) give the moat a real scientific base rather than a pitch deck.
• Bargaining power: low today — Zap needs government validation and capital far more than counterparties need Zap. The DOE Milestone stamp is used explicitly as a fundraising catalyst (Lens 9), i.e. Zap is the supplicant.

Durability test: the moat holds only if the SFS concept actually scales to Q>1 at the modest ~650 kA currents the modeling promises. If it needs 2–3x more current/energy than modeled, the "cheap and small" moat evaporates and Zap becomes a smaller, worse-funded tokamak competitor. The moat is conditional on physics not yet demonstrated.

Segments (+private → business lines, not revenue segments)

No revenue → no reportable segments. The company splits into three internal programs, now spanning two nuclear technologies:

The mix shift is the story: for eight years Zap was 100% fusion; as of April 2026 the near-term commercial weight moved to fission, which management frames as a bridge that funds the fusion endgame. Read generously, that is disciplined revenue-sequencing; read critically (Lens 13), it is a fusion-timeline slip dressed as strategy.

---

Phase B — Measure performance (+private overlay)

Funding & Valuation Trajectory (swaps "Earnings Result")

• Total raised: ~$323–338M — sources disagree on the exact figure (Wikipedia $323.5M; TechCrunch Jun-2026 $327M; Crunchbase ~$330M; energystartups $337.8M). Conflict surfaced, not silently resolved: the spread is the Series D exact size + whether SAFEs/grants are counted. Treat as ~$330M.
• Valuation: last public marker is >$1B (WEF unicorn, Jun 2023), before the Oct-2024 Series D. No post-money has been disclosed since. A flat-to-up Series D would imply ~$1.2–1.5B. Honest answer: n/a — post-2023 valuation not sourced.
• Burn signal: ~150 staff + heavy pulsed-power hardware.. This is a rough arithmetic estimate, not disclosed — but it frames why "fission revenue within a year" matters: the pivot is also a runway story.

Founder / Management Comms (sentiment trend) (+private → interviews/PR, not earnings calls)

No earnings calls exist. Tracking the public-communications tone across 2022→2026:

• 2022–2024 (Conway/Shumlak era): pure-play fusion optimism — "garage-sized reactors," breakeven-device first plasmas, race-to-Q>1 framing.
• 2025 (engineering proof era): tone shifts from "will it fuse" to "can we run it repeatedly" — Century, liquid metal, "lightning 12 times per minute," electrode durability. This is a maturation tell: the hard problem publicly reframed from physics to engineering duty-cycle.
• April 2026 (Johal era): decisive rhetorical break — "an integrated nuclear future: fission today, fusion tomorrow" and "revenue within a year". The vocabulary the company stopped using is telling: less "breakeven soon," more "baseload," "deployment," "milestone payments." Sentiment moved from scientific triumphalism to commercial pragmatism under AI-demand cover.

Cap Table & Peer Comps (+private → syndicate quality + funding-scale comps)

Syndicate quality (an IPO-proximity / conviction tell): climate-tier VCs (Lowercarbon, Breakthrough Energy Ventures, DCVC, Energy Impact Partners), strategic energy majors (Shell, Chevron), and — critically — crossover/marquee capital in the Series D (Soros Fund Management, Emerson Collective). Strategic-major + crossover presence is a genuine quality signal; the absence of a classic pre-IPO crossover mutual fund (Fidelity/T. Rowe) is consistent with "unicorn, but not IPO-imminent."

Funding-scale comps (private fusion, multiples are n/a — none are public; the scoreboard is capital raised):

Read: Zap is a credible mid-tier — roughly at Tokamak Energy's scale, an order of magnitude below the CFS/Helion/TAE leaders. Its whole differentiation is that $327M has to buy what rivals spend billions on. If capital efficiency is real, mid-tier funding is fine; if it isn't, Zap is under-capitalized for a magnet-or-laser fallback. Note Helion's $15.5B mark and TAE's SPAC-via-Trump-Media route show the sector's late-stage capital is concentrating in the leaders — a financing-risk backdrop for everyone below the top tier.

Perception Catalysts (funding/product/strategy events that moved the narrative) (+private → no stock, so narrative inflections)

Events that materially moved Zap's standing (no ticker; these are reputational/valuation inflections):

• Jun 2022 — FuZE-Q first plasmas + Series C: put Zap on the fusion map.
• May–Jun 2023 — DOE Milestone award + WEF unicorn + ICAR asset buy: institutional validation trifecta.
• Feb 2025 — LLNL-corroborated neutron isotropy result (evidence the neutrons are thermonuclear, not beam-target artifacts): a real physics-credibility marker that answered a standing skeptic critique of Z-pinches.
• Nov 2025 — FuZE-3 gigapascal pressure (830 MPa electron / ~1.6 GPa total): highest ever in an SFS Z-pinch.
• Mar 2026 — TIME/Statista Top GreenTech #16, highest-ranked fusion company.
• Apr 2026 — fission-fusion pivot + Zabrina Johal CEO: the single biggest strategic inflection — reframes the entire investment case from "when Q>1" to "fission revenue now".

Pattern: the market rewards independently-validated physics milestones (LLNL neutron work, gigapascal pressure) and institutional stamps (DOE, WEF). It has not yet had to price a commercial failure — because there's no commercial product to fail. The fission pivot is the first time perception hinges on execution/deployment rather than pure physics.

+private — Traction & unit economics: none disclosed. No ARR, no logos, no delivered energy sales. Century's "39 kW" is test-rig thermal-handling output, not net electricity. Unit economics are n/a — private, not disclosed and pre-product on both legs.

---

Phase C — Judge people & books

Management

• Zabrina Johal — CEO (Apr 2026). The pivot personified. Began as a U.S. Navy nuclear-propulsion officer/engineer; 18 years at General Atomics leading strategic development for its nuclear + defense portfolios; then AtkinsRéalis (Montreal nuclear engineering). This is a deployment/defense/fission operator, not a plasma physicist — an unambiguous signal that Zap's near-term center of gravity is government fission contracts and reactor deployment, not fusion science. Strong hire for the fission strategy; a tell about where revenue is expected.
• Benj Conway — Co-founder, President (was CEO). Non-technical founder: ex-British diplomat (Foreign & Commonwealth Office), medicine at Cambridge/Oxford, award-winning restaurateur, founder of InFrontier (frontier-markets PE). A capital-raiser/operator archetype — effective at building the company and syndicate, not a physics authority. His step-aside to President is an orderly founder-to-professional-CEO transition, common at the deployment stage.
• Uri Shumlak — Co-founder, Chief Science Officer. UW Professor of Aeronautics & Astronautics; originator of the SFS Z-pinch concept — the scientific soul of the company, deep credibility, decades of peer-reviewed work.
• Brian A. Nelson — Co-founder, CTO. Ex-UW research professor, 35+ years plasma physics.

Capital allocation: disciplined for a pre-revenue deep-tech — internalized pulsed-power manufacturing (ICAR), leaned hard on non-dilutive DOE cost-share to stretch equity, and staged Century (engineering) in parallel with FuZE (physics) rather than betting everything on breakeven-first. Skin in the game: founder-led with co-founders still in C-suite roles — good alignment; exact insider ownership n/a — private, not disclosed. Archetype: founder-scientist core (Shumlak/Nelson) + capital-operator founder (Conway), now topped by a professional deployment CEO (Johal) — the right shape for a company pivoting from lab to government-contract revenue, provided the science founders retain authority over the fusion endgame.

Forensic Red Flags + Regulatory

No audited financials exist — classic forensic-accounting analysis is not applicable (private, no filings). Reframed for a private deep-tech:

• Milestone-selectivity risk: private fusion PR emphasizes best-shot peak parameters (e.g. "1.6 GPa … sustained ~1 microsecond," "39 kW") — legitimate physics, but peak, transient, single-metric figures that don't equal sustained net performance. Not fraud; a bias to watch.
• Two-metric substitution: watch for the company leaning on the fission narrative and TIME/greentech rankings when fusion Q-progress is slow. The April-2026 pivot conveniently shifts the scoreboard from an unmet physics milestone (Q>1) to a fundable commercial one (fission revenue) — a narrative-management pattern worth flagging, not condemning.
• Regulatory (from regulatory/regulatory-findings.md ): 0 SEC findings — Zap has no CIK, is private, and is not required to file. No SEC Litigation Releases or AAERs are searchable.
• Non-SEC web sweep ("Zap Energy" (FTC/DOJ/FDA/consent decree/settlement/fine/penalty)): no material enforcement actions surfaced.
• New regulatory exposure from the fission leg: entering fission means NRC licensing — and the 4S design has never completed U.S. licensing or been deployed anywhere despite decades of Japanese R&D. That is a material, forward regulatory risk Zap has voluntarily taken on.

Finding: No material regulatory or legal findings — verified via SEC EDGAR EFTS (no CIK), web enforcement search, and the absence of any public litigation, as of 2026-07-10. The real "red flag" is prospective, not historical: an unlicensed, never-deployed fission design as the near-term revenue engine.

---

Phase D — Project & stress-test

IPO-Readiness & Path-to-Tradeable (+private → swaps EPS projection)

There is no EPS to project (pre-revenue) and no rNPVrNPVWhat a drug might eventually be worth, multiplied by the odds it ever gets approved. A way of pricing a lottery ticket rather than a business. that isn't fiction at this stage. The lens that matters: what unlocks a tradeable security, and when?

• Current stage: late-Series-D unicorn, not IPO-ready. No S-1, no disclosed post-2023 valuation, pre-revenue on both legs.
• Milestones that would unlock an S-1 / late-stage crossover round:

1. A signed, funded fission milestone contract (DoD/DOE or a data-center capacity reservation) — management's own "revenue within a year" claim; the nearest catalyst and the one most likely to be real. This is the be-early trigger.
2. Independently-validated Q≥1 (scientific breakeven) at ~650 kA — the fusion prize; modeling says achievable, no date committed.
3. A crossover-fund-led up round (Fidelity/T. Rowe/Coatue) at a disclosed mark — the classic IPO-proximity tell, not yet present.

• Estimated window: fission revenue 2027; fission product to market and a plausible IPO conversation early-2030s, contingent on the 4S clearing NRC. Fusion grid electricity "early 2030s" is the industry-standard aspiration and should be discounted heavily.
• Write-back: no private-watch.json entry exists for zap-energy; this dossier is the first structured IPO-readiness read on the shelf. (Per wave boundaries, not editing that file in this unattended run — flag for the privates ledger: stage = late-Series-D unicorn, readiness = LOW/2030s, catalyst = first fission milestone contract 2027.)

No Brier forecast logged (per --watchlist rule + task constraint: no our model create). The scoreable claim, when logged later, should be binary on the near catalyst — e.g. "Zap Energy books first fission-program revenue by 2026-12-31."

Bull vs Bear

Bull. Zap owns the cheapest credible path to fusion. No magnets, no lasers means an order-of-magnitude less capital and a manufacturable core — and the physics is advancing on independently-corroborated markers (thermonuclear neutron isotropy, gigapascal pressure). The April-2026 fission pivot converts a pure moonshot into a funded, revenue-bearing company riding the largest energy-demand wave in a generation (AI baseload), with a defense/fission CEO who can actually win government contracts. If SFS scales to Q>1 near the modeled ~650 kA, Zap becomes the low-cost producer in a trillion-dollar market while self-funding via fission. Non-dilutive DOE validation de-risks each raise.

Bear (2–3 permanent-impairment risks). (1) The physics doesn't scale cheaply. If Q>1 needs materially more current/energy than modeling promises, the entire cost moat — the only moat — collapses and Zap is a subscale, underfunded also-ran versus CFS/Helion. (2) The rep-rate / electrode wall. A power plant needs ~50–100x Zap's current 0.2 Hz shot rate, sustained for months, with electrodes that today erode under high current. That is an unsolved engineering regime, not a funding problem. (3) The fission pivot is a tell. Reviving a never-U.S.-licensed 4S design as your near-term revenue engine, and hiring a fission CEO, is what a company does when fusion revenue is further away than the last pitch implied.

Pre-mortem (18 months out, thesis broke): FuZE-3's successor plateaus well short of Q>1; the "revenue within a year" fission contracts slip on NRC pre-licensing reality; the leaders (CFS/Helion) hit their milestones and vacuum up the late-stage capital, leaving Zap to raise a flat/down round or lean entirely on government cost-share. The company survives as a DOE-funded R&D shop — not the outcome the unicorn mark implies.

Multiples too high? n/a — no public mark to test; the >$1B (2023) unicorn tag is stale and pre-pivot.

Contrarian view (what the market refuses to see): the crowd treats the fission pivot as dilution of focus / an admission of defeat. The sharper read is the opposite — it's the most commercially rational thing any private fusion company has done: fission gives Zap a real P&L and NRC/deployment muscle years before fusion could, and that revenue is what buys the shots on Q>1. The risk isn't that Zap added fission; it's that the 4S specifically is an old, unlicensed design and the execution is unproven.

Devil's Advocate (short-seller)

Dismantling the bull case:

• Revenue is 100% concentrated in the U.S. government (DOE cost-share today; DoD/DOE fission tomorrow). One appropriations cycle or program cancellation and the "revenue within a year" story is gone. That is not diversified traction — it's a single political counterparty.
• The moat is a hypothesis, not a fact. "Cheaper because no magnets" only matters if the cheap machine reaches net gain. No SFS Z-pinch — Zap's or anyone's — has shown Q≥1. The bull case rests entirely on a scaling extrapolation from ~1-microsecond, single-shot peak-pressure data.
• Most dangerous competitor bulls underrate: Helion. Also magnet-light-ish, far better capitalized ($1.5B, $15.5B mark), with a contracted Microsoft offtake and a 2028 electricity target. If Helion delivers anything on that timeline, it defines "capital-efficient pulsed fusion" and strands Zap's differentiation.
• The fission bet imports a whole new failure surface. Zap has zero reactor-licensing track record and is reviving a design (4S) that Toshiba/CRIEPI could not get deployed in ~20 years. "Revenue within a year" from an unlicensed fast reactor is an aggressive claim; realistic first cash is likely paper study / milestone money, not deployment revenue.
• Capital-allocation risk: splitting a ~150-person, ~$330M-total company across two nuclear technologies risks doing neither at leader scale — the classic deep-tech focus-dilution trap.
• What breaks it permanently: the ~650 kA breakeven modeling proves optimistic by 2–3x (plausible — every fusion program in history has under-estimated the gap), and the leaders soak up late-stage capital. Then Zap can't fund the harder machine and is capped as a government R&D contractor. Plausibility: moderate-to-high on the physics slip; that's the base rate for fusion.

15 Management Questions (ordered by information value)

1. What pinch current, plasma pressure, and confinement time does your model say Q=1 requires — and how far is FuZE-3's 1.6 GPa / ~1 µs from that, quantitatively?
2. Give a date (or the specific gate) for a scientifically-independent Q≥1 demonstration. If you won't, what's the blocker?
3. "Revenue within a year" from fission — is that a signed contract, a milestone/study award, or a reservation? Name the counterparty type and dollar range.
4. Why the 4S specifically, given it has never completed U.S. NRC licensing? What's your realistic licensing timeline and cost, and who funds it?
5. What is your current monthly burn and cash runway, and how much of the fission program is self-funded vs. government cost-share?
6. Century runs at 0.2 Hz. Walk me through the concrete path to the ~10+ Hz, months-long duty cycle a plant needs — and the electrode-life data behind it.
7. How does splitting ~150 people across fission and fusion not slow both? Show me the org/resource split.
8. What insider/founder ownership remains post-Series-D, and what governance protects the fusion science mission under a fission/defense CEO?
9. Helion has $1.5B and a Microsoft offtake for 2028. What do you do that they can't, and why won't they strand your cost moat?
10. What is the tritium supply-and-breeding plan for a D-T plant, and what does it add to unit cost?
11. What was the Series D post-money, and why hasn't a crossover fund led a round yet?
12. Which prior public parameter forecasts did you miss, and what did that teach you about your scaling model?
13. What single experimental result in the next 12 months would most change your own confidence — up or down?
14. If fusion Q>1 slips past 2032, what is the standalone equity value of the fission business — and would you spin it out?
15. What would make you abandon SFS Z-pinch entirely?

---